These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 33029698)

  • 1. The role of cardiac magnetic resonance imaging in the detection and monitoring of cardiotoxicity in patients with breast cancer after treatment: a comprehensive review.
    Jafari F; Safaei AM; Hosseini L; Asadian S; Kamangar TM; Zadehbagheri F; Rezaeian N
    Heart Fail Rev; 2021 May; 26(3):679-697. PubMed ID: 33029698
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Myocardial injury detected by T1 and T2 mapping on CMR predicts subsequent cancer therapy-related cardiac dysfunction in patients with breast cancer treated by epirubicin-based chemotherapy or left-sided RT.
    Tahir E; Azar M; Shihada S; Seiffert K; Goy Y; Beitzen-Heineke A; Molwitz I; Muellerleile K; Stehning C; Schön G; Adam G; Petersen C; Müller V; Lund GK
    Eur Radiol; 2022 Mar; 32(3):1853-1865. PubMed ID: 34536111
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Early Detection and Serial Monitoring of Anthracycline-Induced Cardiotoxicity Using T1-mapping Cardiac Magnetic Resonance Imaging: An Animal Study.
    Hong YJ; Park HS; Park JK; Han K; Park CH; Kim TK; Yoo SJ; Lee JY; Kim PK; Hur J; Lee HJ; Kim YJ; Suh YJ; Paek MY; Choi BW
    Sci Rep; 2017 Jun; 7(1):2663. PubMed ID: 28572614
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardiotoxicity evaluation using magnetic resonance imaging in breast Cancer patients (CareBest): study protocol for a prospective trial.
    Hong YJ; Kim GM; Han K; Kim PK; Lee SA; An E; Lee JY; Lee HJ; Hur J; Kim YJ; Kim MJ; Choi BW
    BMC Cardiovasc Disord; 2020 Jun; 20(1):264. PubMed ID: 32493217
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiac magnetic resonance imaging-based myocardial strain study for evaluation of cardiotoxicity in breast cancer patients treated with trastuzumab: A pilot study to evaluate the feasibility of the method.
    Nakano S; Takahashi M; Kimura F; Senoo T; Saeki T; Ueda S; Tanno J; Senbonmatsu T; Kasai T; Nishimura S
    Cardiol J; 2016; 23(3):270-80. PubMed ID: 27173679
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serial Cardiovascular Magnetic Resonance Strain Measurements to Identify Cardiotoxicity in Breast Cancer: Comparison With Echocardiography.
    Houbois CP; Nolan M; Somerset E; Shalmon T; Esmaeilzadeh M; Lamacie MM; Amir E; Brezden-Masley C; Koch CA; Thevakumaran Y; Yan AT; Marwick TH; Wintersperger BJ; Thavendiranathan P
    JACC Cardiovasc Imaging; 2021 May; 14(5):962-974. PubMed ID: 33248962
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Left ventricular myocardial strain and tissue characterization by cardiac magnetic resonance imaging in immune checkpoint inhibitor associated cardiotoxicity.
    Higgins AY; Arbune A; Soufer A; Ragheb E; Kwan JM; Lamy J; Henry M; Cuomo JR; Charifa A; Gallegos C; Hull S; Coviello JS; Bader AS; Peters DC; Huber S; Mojibian HR; Sinusas AJ; Kluger H; Baldassarre LA
    PLoS One; 2021; 16(2):e0246764. PubMed ID: 33606757
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serial Magnetic Resonance Imaging to Identify Early Stages of Anthracycline-Induced Cardiotoxicity.
    Galán-Arriola C; Lobo M; Vílchez-Tschischke JP; López GJ; de Molina-Iracheta A; Pérez-Martínez C; Agüero J; Fernández-Jiménez R; Martín-García A; Oliver E; Villena-Gutierrez R; Pizarro G; Sánchez PL; Fuster V; Sánchez-González J; Ibanez B
    J Am Coll Cardiol; 2019 Feb; 73(7):779-791. PubMed ID: 30784671
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Can Quantitative CMR Tissue Characterization Adequately Identify Cardiotoxicity During Chemotherapy?: Impact of Temporal and Observer Variability.
    Altaha MA; Nolan M; Marwick TH; Somerset E; Houbois C; Amir E; Yip P; Connelly KA; Michalowska M; Sussman MS; Wintersperger BJ; Thavendiranathan P
    JACC Cardiovasc Imaging; 2020 Apr; 13(4):951-962. PubMed ID: 31864977
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Late characterisation of cardiac effects following anthracycline and trastuzumab treatment in breast cancer patients.
    Kimball A; Patil S; Koczwara B; Raman KS; Perry R; Grover S; Selvanayagam J
    Int J Cardiol; 2018 Jun; 261():159-161. PubMed ID: 29576422
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of subclinical diastolic dysfunction by cardiac magnetic resonance feature-tracking in adult survivors of non-Hodgkin lymphoma treated with anthracyclines.
    Barbosa MF; Fusco DR; Gaiolla RD; Werys K; Tanni SE; Fernandes RA; Ribeiro SM; Szarf G
    BMC Cardiovasc Disord; 2021 Apr; 21(1):170. PubMed ID: 33845778
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessment of left ventricular function by CMR versus MUGA scans in breast cancer patients receiving trastuzumab: a prospective observational study.
    Dhir V; Yan AT; Nisenbaum R; Sloninko J; Connelly KA; Barfett J; Haq R; Kirpalani A; Chan KKW; Petrella TM; Brezden-Masley C
    Int J Cardiovasc Imaging; 2019 Nov; 35(11):2085-2093. PubMed ID: 31197526
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiac Magnetic Resonance Imaging and Blood Biomarkers for Evaluation of Radiation-Induced Cardiotoxicity in Patients With Breast Cancer: Results of a Phase 2 Clinical Trial.
    Speers C; Murthy VL; Walker EM; Glide-Hurst CK; Marsh R; Tang M; Morris EL; Schipper MJ; Weinberg RL; Gits HC; Hayman J; Feng M; Balter J; Moran J; Jagsi R; Pierce LJ
    Int J Radiat Oncol Biol Phys; 2022 Feb; 112(2):417-425. PubMed ID: 34509552
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiac MRI for the evaluation of oncologic cardiotoxicity.
    Löffler AI; Salerno M
    J Nucl Cardiol; 2018 Dec; 25(6):2148-2158. PubMed ID: 29736616
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardiovascular imaging in the diagnosis and monitoring of cardiotoxicity: cardiovascular magnetic resonance and nuclear cardiology.
    Pepe A; Pizzino F; Gargiulo P; Perrone-Filardi P; Cadeddu C; Mele D; Monte I; Novo G; Zito C; Di Bella G
    J Cardiovasc Med (Hagerstown); 2016 May; 17 Suppl 1():S45-54. PubMed ID: 27183525
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Variability in echocardiography and MRI for detection of cancer therapy cardiotoxicity.
    Lambert J; Lamacie M; Thampinathan B; Altaha MA; Esmaeilzadeh M; Nolan M; Fresno CU; Somerset E; Amir E; Marwick TH; Wintersperger BJ; Thavendiranathan P
    Heart; 2020 Jun; 106(11):817-823. PubMed ID: 32098808
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardiovascular Magnetic Resonance Imaging in the Early Detection of Cardiotoxicity Induced by Cancer Therapies.
    Wei X; Lin L; Zhang G; Zhou X
    Diagnostics (Basel); 2022 Jul; 12(8):. PubMed ID: 36010197
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low to moderate dose anthracycline-based chemotherapy is associated with early noninvasive imaging evidence of subclinical cardiovascular disease.
    Drafts BC; Twomley KM; D'Agostino R; Lawrence J; Avis N; Ellis LR; Thohan V; Jordan J; Melin SA; Torti FM; Little WC; Hamilton CA; Hundley WG
    JACC Cardiovasc Imaging; 2013 Aug; 6(8):877-85. PubMed ID: 23643285
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessing for Cardiotoxicity from Metal-on-Metal Hip Implants with Advanced Multimodality Imaging Techniques.
    Berber R; Abdel-Gadir A; Rosmini S; Captur G; Nordin S; Culotta V; Palla L; Kellman P; Lloyd GW; Skinner JA; Moon JC; Manisty C; Hart AJ
    J Bone Joint Surg Am; 2017 Nov; 99(21):1827-1835. PubMed ID: 29088037
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Early diagnosis of chemotherapy-induced cardiotoxicity by cardiac MRI.
    Cau R; Bassareo P; Cherchi V; Palmisano V; Suri JS; Porcu M; Balestrieri A; Pontone G; Saba L
    Eur J Radiol; 2020 Sep; 130():109158. PubMed ID: 32652404
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.